MTOR and renal cell carcinoma: 786-O, ACHN and 769P cells were utilized to elucidate a new mechanism by which PLCL1 activates the AMPK/mTOR pathway, induces autophagosome formation, suppresses autophagic degradation and promotes proapoptotic protein expression, suppressing progression and accelerating apoptosis in RCC.